• Stephen Poole, Nathan J Brendish, and Tristan W Clark.
• NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust Southampton, UK; Department of Infection, University Hospital Southampton NHS Foundation Trust Southampton, UK. Electronic address: S.Poole@soton.ac.uk.
• J. Infect. 2020 Dec 1; 81 (6): 966-972.

ObjectivesThe effect of SARS-CoV-2 on existing respiratory viruses in circulation and the overall burden of viral respiratory disease remains uncertain. Traditionally, severe viral respiratory disease disproportionally affects those with underlying chronic lung diseases. This study aimed to assess the impact of SARS-CoV-2 on the prevalence and clinical characteristics of respiratory virus disease in hospitalised adults.MethodsData for this cohort study were from hospitalised adults who had multiplex PCR testing for respiratory viruses over several seasons in Hampshire, UK. Respiratory virus detection during the first epidemic peak of SARS-CoV-2 was compared to detection during the same time period across previous years.Results856 patients had multiplex PCR for respiratory viruses between March and May over 5 years. Before 2020, a non-SARS-CoV-2 virus was detected in 54% patients (202/371) compared to 4.1% (20/485) in 2020 (p < 0.0001). SARS-CoV-2 was associated with asthma or COPD exacerbations in a smaller proportion of infected patients compared to other viruses (1.0% vs 37%, p < 0.0001).ConclusionsThe emergence of SARS-CoV-2 was associated with substantial reductions in the circulation of seasonal respiratory viruses and large differences in the characteristics of viral-associated disease, including illness in a greater proportion of patients without underlying lung disease.Copyright © 2020. Published by Elsevier Ltd.

36 keywords...

hide…